Trilobio, developer of whole lab automation solutions for advancing biology research, today introduced the first version of ...

Myriad Genetics (MYGN) announced that the United States Patent ... MRD methods that are performed via an automation system configured to interface with laboratory equipment. U.S. patent No. 12,215,392 ...

SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MYGN), a leader in genetic and tumor genomic testing and ...

Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...

Trilobio, developer of whole lab automation systems for biology research, introduced the first version of its comprehensive robotics, lab equipment and software platform.

Trilobio was founded to improve genetic engineering, synthetic biology and life science research processes by building robotic lab automation modules coupled with an application store to package ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and tumor genomic testing and precision medicine, announced that the United States Patent and ...

SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine with annual revenues of $824 million, has announced the issuance of two ...

A group of Rutgers scientists, led by ecologist Julie Lockwood, met an international challenge and has been recognized for ...

Cell culture is a key technique in scientific research. It lets scientists grow and study cells outside their natural ...

Pathology Lab Equipment Market Growth Secured At 6.37% CAGR To Achieve 25.0 Billion USD By 2032 Leica Biosystems The Global Pathology Lab Equipment market is driven by several key factors, including ...